BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 16714455)

  • 1. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response.
    Provenzale JM; Mukundan S; Barboriak DP
    Radiology; 2006 Jun; 239(3):632-49. PubMed ID: 16714455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnetic resonance imaging with spectroscopy, perfusion and cerebral diffusion in the diagnosis of brain tumours].
    Fayed-Miguel N; Morales-Ramos H; Modrego-Pardo PJ
    Rev Neurol; 2006 Jun 16-30; 42(12):735-42. PubMed ID: 16775800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain tumors: a multimodality approach with diffusion-weighted imaging, diffusion tensor imaging, magnetic resonance spectroscopy, dynamic susceptibility contrast and dynamic contrast-enhanced magnetic resonance imaging.
    Brandão LA; Shiroishi MS; Law M
    Magn Reson Imaging Clin N Am; 2013 May; 21(2):199-239. PubMed ID: 23642551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion MR imaging: an important tool in the assessment of brain tumors.
    Hygino da Cruz LC; Vieira IG; Domingues RC
    Neuroimaging Clin N Am; 2011 Feb; 21(1):27-49, vii. PubMed ID: 21477750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives.
    Svolos P; Kousi E; Kapsalaki E; Theodorou K; Fezoulidis I; Kappas C; Tsougos I
    Cancer Imaging; 2014 Apr; 14(1):20. PubMed ID: 25609475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced neuroimaging of pediatric brain tumors: MR diffusion, MR perfusion, and MR spectroscopy.
    Poussaint TY; Rodriguez D
    Neuroimaging Clin N Am; 2006 Feb; 16(1):169-92, ix. PubMed ID: 16543091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion and perfusion MR imaging.
    Valentini V; Gaudino S; Spagnolo P; Armenise S; Tartaglione T; Marano P
    Rays; 2003; 28(1):29-43. PubMed ID: 14509178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
    Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
    Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
    Warmuth C; Gunther M; Zimmer C
    Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance perfusion and permeability imaging in brain tumors.
    Lacerda S; Law M
    Neuroimaging Clin N Am; 2009 Nov; 19(4):527-57. PubMed ID: 19959004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
    Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging in assessment of treatment response of gamma knife for brain tumors.
    Gao X; Zhang XN; Zhang YT; Yu CS; Xu DS
    Chin Med J (Engl); 2011 Jun; 124(12):1906-10. PubMed ID: 21740852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients.
    Cha S
    Neuroimaging Clin N Am; 2006 Feb; 16(1):137-47, ix. PubMed ID: 16543089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in magnetic resonance imaging of brain tumours.
    Lemort M; Canizares-Perez AC; Van der Stappen A; Kampouridis S
    Curr Opin Oncol; 2007 Nov; 19(6):616-22. PubMed ID: 17906462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging.
    Armitage PA; Schwindack C; Bastin ME; Whittle IR
    Magn Reson Imaging; 2007 Apr; 25(3):303-10. PubMed ID: 17371718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
    Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR
    J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edema and tumor perfusion: characterization by quantitative 1H MR imaging.
    Steen RG
    AJR Am J Roentgenol; 1992 Feb; 158(2):259-64. PubMed ID: 1729777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced MRI of adult brain tumors.
    Young GS
    Neurol Clin; 2007 Nov; 25(4):947-73, viii. PubMed ID: 17964022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of advanced MR imaging in understanding brain tumour pathology.
    Price SJ
    Br J Neurosurg; 2007 Dec; 21(6):562-75. PubMed ID: 18071983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.